You are here: Home » PF » Features » Investments
Harsh Roongta: Banks and fake currency
icon-arrow-left
Business Standard

Your Money: Opt for mid-caps in defensive sector

Large-cap companies in pharma and IT sectors are facing growth slowdown

Topics
Your Money

Tinesh Bhasin 



Once darlings of investors who wanted at stable returns, the pharmaceuticals and information technology (IT) companies have been among the worst performers this year. For the first time in the past five years that these defensives have negative returns.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Wed, December 21 2016. 23:14 IST

RECOMMENDED FOR YOU

.